Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 Guidelines
Therapeutic Innovation & Regulatory Science · 2024
DOI: 10.1007/s43441-024-00639-0 ↗Kurz gefasst
Leitlinie in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2024. Verfasst von Rominder Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Research and Development, 10555 Science Center Dr, San Diego, CA, 92121, USA. drugdevpro@gmail.com. Hauptthemen laut MEDLINE: Drug Development. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pfizer Research and Development, 10555 Science Center Dr, San Diego, CA, 92121, USA. drugdevpro@gmail.com.
- Merck & Co., Inc, 126 East Lincoln Ave, Rahway, NJ, 07065, USA.
- Pfizer Chief Medical Affairs Office, 66 Hudson Boulevard, New York, NY, 10001, USA.
- Center of Drug Evaluation, National Medical Products Administration, Zone 2, No. 22 Guangde Street, Economic and Technological Development Zone, Beijing, China.
- Regulatory Science Center, Pharmaceuticals and Medical Devices Agency, Shin‑Kasumigaseki Building, 3‑3‑2, Kasumigaseki, Chiyoda‑ku, Tokyo, 100‑0013, Japan.
ORCID-Profile: Rominder Singh
Zitieren
APA
Singh, R., Wang, W., Chakravarty, A., Wang, J., & Uyama, Y. (2024). Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 Guidelines. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00639-0
Vancouver
Singh R, Wang W, Chakravarty A, Wang J, Uyama Y. Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 Guidelines. Therapeutic Innovation & Regulatory Science. 2024. doi:10.1007/s43441-024-00639-0
BibTeX
@article{Singh2024,
author = {Singh, Rominder and Wang, William and Chakravarty, Aloka and Wang, Jun and Uyama, Yoshiaki},
title = {Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 Guidelines},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2024},
doi = {10.1007/s43441-024-00639-0}
}
EUVIMED